AUPH · Aurinia Pharmaceuticals Inc.
$15.24
-0.09 (-0.59%)
At close · Jul 23
Market Cap
$1.96B
Shares
128.60M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-05 | GREGORY KEENAN | Former Affiliate | 9,593 | 2026-06-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-04 | GREGORY KEENAN | Former Affiliate | 25,000 | 2026-06-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-02 | GREGORY KEENAN | Officer | 25,000 | 2026-06-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-11 | PETER GREENLEAF | Former Affiliate | 3,136,201 | 2026-05-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-11 | JOSEPH MILLER | Former Affiliate | 500,503 | 2026-05-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-11 | MATTHEW MAXWELL DONLEY | Former Affiliate | 717,688 | 2026-05-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–6 of 6 filings
Key facts
CIK
1600620
CUSIP
05156V102
13F (30d)
41 filings
41 filers
Visit website
Investor relations